The findings of decreased total tau levels in the cortex of AD patients and the requirement of tau for the trafficking of APP to the neuronal membrane support the idea that disruptions in tau and APP levels can lead to the retention of iron in neurons, which is a hallmark of AD.34, 233. The gene discussed is MAPT; the disease is Alzheimer disease.